DIA/MEB Excellence in Pharmacovigilance: GVP Modules I to XVI Amsterdam, The Netherlands
13.10.26 - 16.10.26
A strong foundation in all key aspects of European post-marketing safety regulatory requirements, delivered in collaboration with the Dutch Medicines Evaluation Board (MEB).
Join this intermediate-level face-to-face course in Amsterdam, delivered in collaboration with the Dutch Medicines Evaluation Board (MEB).
Combining lectures, exercises, and extensive interaction with trainers and peers, the programme covers all major pharmacovigilance processes outlined in GVP Modules I to XVI, including ICSR reporting, signal management, risk management, quality management systems, and the latest updates on PV legislation and ICH activities.